Neumora Therapeutics, Inc. reports

Company location: Watertown, MA
Fiscal year end: 31 December

Neumora Therapeutics, Inc. has filed 244 SEC EDGAR filings since 08 Nov 2021

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 151-175 of 244 matching filings.

Per page

25

Current page

7

4

4 filing

Filing date: 16 Feb 2024
Reporting date: 14 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Feb 2024
Reporting date: 14 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Feb 2024
Reporting date: 14 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Feb 2024
Reporting date: 14 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-94162

SC 13G

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-94162

SC 13G filing

Filing date: 13 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-41802

8-K

Filing date: 08 Jan 2024
Reporting date: 08 Jan 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D/A File 005-94162

ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#1)

Filing date: 15 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 12 Dec 2023
Reporting date: 08 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 12 Dec 2023
Reporting date: 08 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 12 Dec 2023
Reporting date: 08 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 12 Dec 2023
Reporting date: 11 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 12 Dec 2023
Reporting date: 11 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-41802

8-K

Filing date: 28 Nov 2023
Reporting date: 27 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 15 Nov 2023
Reporting date: 13 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 15 Nov 2023
Reporting date: 13 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 13 Nov 2023
Reporting date: 08 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 13 Nov 2023
Reporting date: 08 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 07 Nov 2023
Reporting date: 03 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 07 Nov 2023
Reporting date: 03 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-41802

10-Q

Filing date: 01 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41802

8-K

Filing date: 01 Nov 2023
Reporting date: 01 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D File 005-94162

ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D

Filing date: 02 Oct 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 29 Sep 2023
Reporting date: 28 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 29 Sep 2023
Reporting date: 28 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .